Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda
Clinical Trial Preparation WASHINGTON, Oct. 19, 2023 (GLOBE NEWSWIRE) — The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus. Healthy volunteers received the single-dose vaccine at Makerere University Walter Reed Project (MUWRP) in Kampala, Uganda today. There are currently no vaccines or antiviral treatments […]